Benzopyrancarboxylic acid derivatives for the treatment of...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 311/66 (2006.01) A61K 31/353 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2423141

A class of benzopyrancarboxylic acid derivatives comprises compounds that are potent agonists of PPAR alpha and/or gamma, and are therefore useful in the treatment, control or prevention of non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, obesity, vascular restenosis, inflammation, and other PPAR alpha and/or gamma mediated diseases, disorders and conditions.

Cette invention concerne une classe de dérivés de l'acide benzopyrancarboxylique comprenant des composés qui sont des agonistes puissance de du récepteur PPAR alpha et/ou gamma, et qui permettent donc bien de traiter, combattre ou prévenir le diabète sucré non insulinodépendant, l'hyperglycémie, la dyslipidémie, l'hyperlipidémie, l'hypercholesterolémie, l'hypertriglyceridémie, l'athérosclerose, l'obésité, la resténose vasculaire, les troubles inflammatoires et autres maladies, troubles et états pathologiques induits par le récepteur PPAR alpha et/ou gamma.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Benzopyrancarboxylic acid derivatives for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzopyrancarboxylic acid derivatives for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzopyrancarboxylic acid derivatives for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1459308

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.